We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOA:NYSEFinance of America Companies Inc. Analysis

Data as of 2026-06-26 - not real-time

$21.66

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Finance of America Companies (FOA) trades at a trailing P/E of 9.6 versus an industry average of 16.9, and a price‑to‑book of 0.53, suggesting a substantial valuation discount. Technical indicators show a bullish MACD crossover (MACD line 0.31 above signal 0.10) but the SMA‑20 (20.02) sits below the SMA‑50 (20.36) and SMA‑200 (21.49), confirming a bearish trend direction. Momentum is elevated with an RSI of 65.6, approaching overbought levels, while volume is increasing, indicating heightened trader interest. The stock’s beta of 1.73 and 30‑day volatility of 38.6% point to pronounced price swings, and the max drawdown of –45% underscores historical downside risk. Fundamentally, the company posted a net income of $35 M and a 112% rise in adjusted EPS YoY, yet operating cash flow remains negative (‑$468 M) and debt‑to‑equity is extreme at 2670, highlighting balance‑sheet stress. The recent quarterly funded volume rose 6% to $596 M, driven by growth in reverse‑mortgage products, supporting top‑line momentum. With an upside estimate of ~15% and a “Extreme Greed” market sentiment, FOA sits at a crossroads between valuation appeal and financial fragility.
Investors should weigh the attractive multiples and earnings acceleration against the high leverage, negative cash generation, and volatile price action when determining positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish SMA alignment despite bullish MACD
  • Elevated RSI and high volatility
  • Proximity to resistance near $23.68

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong earnings growth and 112% EPS increase
  • Significant valuation discount to peers
  • Upside potential of ~15% with improving funded volume

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Heavy debt load and negative operating cash flow
  • Regulatory exposure inherent to reverse‑mortgage business
  • Sustained low price‑to‑book and price‑to‑sales ratios

Key Metrics & Analysis

Financial Health

Revenue Growth-27.50%
Profit Margin7.20%
P/E Ratio9.6
ROE15.60%
ROA0.21%
Debt/Equity2670.33
P/B Ratio0.5
Op. Cash Flow$-468526016
Industry P/E16.9

Technical Analysis

TrendBearish
RSI65.6
Support$18.85
Resistance$23.68
MA 20$20.02
MA 50$20.36
MA 200$21.49
MACDBullish
VolumeIncreasing
Fear & Greed Index86.23

Valuation

Target Price$25.00
Upside/Downside15.42%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.73
Volatility38.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.